UCP3 (uncoupling protein-3) mitigates mitochondrial ROS (reactive oxygen species) production, but the mechanisms are poorly understood. Previous studies have also examined UCP3 effects, including decreased ROS production, during metabolic states when fatty acid oxidation is high (e.g. a fasting state). However, the role of UCP3 when carbohydrate oxidation is high (e.g. fed state) has remained largely unexplored. In the present study, we show that mitochondrial-bound HK (hexokinase) II curtails oxidative stress and enhances aerobic metabolism of glucose in the fed state in a UCP3-dependent manner. Genetic knockout or inhibition of UCP3 significantly decreased mitochondrial-bound HKII. Furthermore, UCP3 was required for the HKII-mediated decrease in mitochondrial ROS emission. Intriguingly, the UCP3-mediated modulation of mitochondriaassociated HKII was only observed in cells cultured under high-glucose conditions. UCP3 was required to maintain high rates of aerobic metabolism in high-glucose-treated cells and in muscle of fed mice. Deficiency in UCP3 resulted in a metabolic shift that favoured anaerobic glycolytic metabolism, increased glucose uptake and increased sensitivity to oxidative challenge. PET (positron emission tomography) of [
INTRODUCTION
The aerobic oxidation of fuels by eukaryotic cells is characterized by high ATP yields as compared with anaerobic mechanisms. Coincident with the use of diatomic oxygen (O 2 ) for aerobic respiration is the generation of ROS (reactive oxygen species), singlet electron carriers that can stress and damage cellular function. Thus aerobic organisms have developed a battery of anti-oxidative defence systems to keep ROS in check. This is especially relevant at the mitochondrial level since the respiratory chain is the major site for cellular ROS production [1, 2] . Mitochondria are abundant in SOD (superoxide dismutase), the GSH (glutathione)/glutathione peroxidase and peroxiredoxin systems, small molecule anti-oxidants and NADPH-generating enzymes to fend against the potential toxicity of ROS [3] [4] [5] [6] . Despite the extent of the anti-oxidative defence arsenal, the loss of even one protective mechanism often has dire consequences for aerobic cellular function. For instance, cells lacking functional mitochondrial SOD display increased oxidative damage and cell death [7] .
Aside from anti-oxidative defence systems, ROS production can also be minimized by efficient electron transfer within the electron transport chain. Indeed, an excess supply of reducing equivalents/electrons to the respiratory complexes and concomitant increases in mitochondrial membrane potential ( ψ m ) can greatly increase electron escape from the chain. An immediate outcome is superoxide formation as electrons interact with O 2 [8] . An additional, yet poorly studied, mechanism limiting mitochondrial ROS emission is the recruitment of HK (hexokinase) I or II to the VDAC (voltage-dependent anion channel)/ANT (adenine nucleotide translocase) ATP/ADP exchanger on the mitochondrial outer membrane [9] . Whereas HKI is found exclusively in the brain, the HKII isoenzyme dominates cardiac tissue and skeletal muscle [10] . In this scenario, HKI or HKII phosphorylates glucose to recycle ADP for coupled respiration. This mechanism, which activates oxidative phosphorylation through ADP provision, also prevents the over-reduction of the complexes and thereby decreases ROS production. Creatine kinase has also been described to function in a similar manner [11] . Maintenance of a high NAD/NADH ratio, formation of respiratory supercomplexes, and the provision of ADP and P i levels are also important controllers of mitochondrial ROS production through the maintenance of efficient aerobic metabolism [12] [13] [14] .
Mild uncoupling of oxidative phosphorylation by UCPs (uncoupling proteins) has also been suggested to limit mitochondrial ROS production by decreasing ψ m (as reviewed in [15] ). Chemical uncouplers such as FCCP (carbonyl cyanide p-trifluoromethoxyphenylhydrazone) and dinitrophenol, and the increased expression of UCPs, have been shown in in vitro systems to decrease mitochondrial ROS emission [13, 16, 17] .
Skeletal muscle is uniquely capable of high rates of fuel oxidation and has remarkable metabolic flexibility, i.e. it can rapidly switch from oxidizing fatty acids to glucose. UCP3 is highly selectively expressed in skeletal muscle tissue and it is generally thought that it functions as an inducible uncoupler [18] . Loss of UCP3 function is accompanied by increased mitochondrial ROS production and oxidative damage [16, 19] . In addition, the presence of UCP3 is known to protect cells and skeletal muscle from oxidative challenge [20, 21] . Acute increases in fatty acid oxidation are associated with increased ROS emission by skeletal muscle mitochondria [22] . Hence, the presence of UCP3 may alleviate the ROS burden associated with the aerobic metabolism of substrates [23] .
To date, an unexplored question relates to the role of UCP3 in the 'fed state', in which cells rely heavily on carbohydrates as fuel substrates. Ignoring questions of mechanism, it is simply unknown whether UCP3 is associated with decreased ROS emission during carbohydrate oxidation. Hence, the aim of the present study was to determine whether UCP3 modulates bioenergetic and ROS emission characteristics of muscle mitochondria and myotubes under conditions of carbohydrate oxidation. In the course of these studies we made the unique observation that under 'fed-state' conditions UCP3 is functionally linked with the activity of mitochondrial-bound HKII. This novel association augments aerobic catabolism of carbohydrates and protects from oxidative stress. Indeed, in the absence of UCP3, there is a metabolic shift to glycolysis (rather than full oxidation of glucose) and increased sensitivity to oxidative stress.
EXPERIMENTAL
All animal experiments were performed according to the principles and guidelines of the Canadian Council of Animal Care and the study was approved by the Animal Care Committee of the University of Ottawa.
Primary myoblast isolation
Muscle satellite cells were isolated as described in [24] from forelimb and hindlimb muscles of 3-week-old WT (wild-type) and UCP3-null [KO (knockout)] mice. Muscle was cleaned and minced on ice in 1.5 ml of dissociation solution [2.4 units/ml dispase, 1 % (w/v) collagenase and 2.5 mM CaCl 2 ]. The solution was then triturated, diluted and then filtered (7.4 micron filter). Homogenate was centrifuged at 200 g for 5 min and the cellular pellet was resuspended in 3 ml of myoblast medium [Ham's F-10 containing 20 % FBS (fetal bovine serum), 2 % A.A. (antibiotics/antimycotics) and 2 ng/ml fibroblast growth factor). Following a 2-4 h incubation on a plastic dish, the supernatant was centrifuged at 200 g for 5 min, and the cell pellet was resuspended in 6 ml of myoblast medium and plated on Matrigel TM -coated 60-mm 2 dishes. Fresh myoblast medium was added daily. To confirm the presence of myoblasts, cells were immunostained for desmin.
Primary cell culture and treatment
Primary myoblasts were maintained and cultured on Matrigel TMcoated 60-mm 2 plates in DMEM (Dulbecco's modified Eagle's medium) containing 25 mM dextrose, 1 mM pyruvate, 4 mM glutamine, 10 % (v/v) FBS and 1 % A.A. Cells were passaged every 2 days (or upon reaching 80 % confluency). For experiments, primary myoblasts were seeded at ∼50000 cells/ml, grown to 70 % confluency, and then differentiated for up to 7 days in DMEM containing 25 mM glucose, 1 mM pyruvate, 4 mM glutamine, 2 % FBS and 2 % A.A (differentiation medium). Cells were then isolated by trypsinization, washed with PBS and then treated appropriately for experimentation.
C2C12 and HEK (human embryonic kidney)-293 cell culture
C2C12 cells were grown and differentiated as described in [3] . HEK-293 cells were grown as described in [3] . For experiments, C2C12 cells were grown to 80 % confluency and then differentiated for up to 7 days. Infection with adenoviral vectors was performed as described in [25] . On day 5 of differentiation, or upon reaching ∼80 % confluency, cells were transduced with either RFP (red fluorescent protein) or UCP3-adenoviral vector at a MOI (multiplicity of infection) of 200 viral particles/cell for C2C12 cells and 100 viral particles/cell for HEK-293 cells. Cells were incubated in the virus for 24 h. The infection medium was then removed and the cells were incubated in differentiation or growth medium for an additional 24 h. Cells were then isolated and treated accordingly for experimentation. Prior to experimentation, the cells were infected with different amounts of adenoviral-UCP3.
Mitochondria were then isolated and tested for UCP3 by immunoblot analysis. Mitochondria isolated from skeletal muscle of a WT mouse served as a control (Supplementary Figure S1 at http://www.BiochemJ.org/bj/437/bj4370301add.htm).
Mitochondrial isolation
Mitochondria from cultured cells were isolated as described in [3] . Cells were resuspended in mitochondrial isolation buffer [Buffer A: 140 mM KCl, 5 mM KH 2 PO 4 , 5 mM Hepes, 5 mM MgCl 2 , 1 mM dithiothreitol, 1 mM EGTA and protease inhibitor cocktail (Roche) (pH 7.4)] containing 1 unit of catalase. Following sonication (power setting at 11 % amplitude, 10 s in 1 s on/off intervals on ice; performed twice), the cell suspension was subjected to differential centrifugation to isolate mitochondrial and cytosolic fractions (cell suspension was spun at 200 g and 800 g at 4
• C to remove whole cells and nuclei; the resulting supernatant was then spun at 12 000 g for 30 min at 4
• C to yield a mitochondrial pellet). Mitochondrial purity was tested by immunoblotting for the mitochondrial and cytosolic protein markers SDH (succinate dehydrogenase; 1:3000 dilution, Santa Cruz Biotechnology) and actin (1:4000 dilution, Cell Signaling Technology).
C57Bl/6J male mice matched for age were fed a standard chow diet (44.2 % carbohydrate, 6.2 % fat and 18.6 % crude protein; T.2018-Harlan) ad libitum and then killed at 10-12 weeks of age. Skeletal muscle mitochondria from WT and KO mice were isolated as described in [26] . Briefly, skeletal muscle from forelimbs and hindlimbs was dissected, cleaned of connective tissue and fat, and placed in ice-cold BM [basic medium: 140 mM KCl, 20 mM Hepes, 5 mM MgCl 2 , 1 mM EGTA and 1 mM dithiothreitol (pH 7.0)]. Muscle was minced and homogenized using the Potter-Elvehjem method. Homogenized tissue was then centrifuged as described in [26] . The resulting mitochondrial pellet was washed once with BM and the final pellet was resuspended in BM containing protease inhibitor cocktail. Protein content was determined using the Bradford assay.
In situ determination of metabolic flux
The metabolic profile of the primary cells from WT and KO mice was ascertained using the Seahorse Extracellular Flux Analyzer (Seahorse XF24 Analyzer, Seahorse Bioscience). Briefly, myoblasts were seeded at 50 000 cells/ml in Matrigel TMcoated Seahorse culture plates, grown to ∼80 % confluency and then differentiated for up to 7 days. For experiments involving menadione, cells were treated 24 h prior to the experiment. Cells were then incubated for 30 min at 37
• C at ambient CO 2 in HCO 3 -free DMEM containing 25 mM glucose, 4 mM glutamine and 1 mM pyruvate (pH 7.4). OCRs (oxygen consumption rates) and ECARs (extracellular acidification rates) were determined in situ using sensitive fluorimetric probes. . Animals were then anaesthetized using 1.5-2.5 % isoflurane prior to performing PET imaging. List-mode data were acquired for 60 min, starting 25 min post-injection. A 350-650 keV energy window and a 3.4 ns coincidence timing window were used. After rebinning the list-mode data to a 3D (three-dimensional) sinogram, images were reconstructed using OSEM3D/MAP (β = 0, OSEM3D iterations = 2, MAP iterations = 18) on to a 256×256×159 matrix with 0.17×0.17×0.80 mm pixels. Corrections for detector dead-time, isotope decay, detector efficiencies and randoms were performed. Images were loaded into the Inveon Research Workplace software (Siemens) and SUVs (standardized uptake values) were computed (SUV = activity concentration/injected dose × body weight). Contour ROIs (regions of interest) were drawn, thresholded to an SUV of 1 g/ml; the forelimb and hindlimb skeletal muscle and the mean and maximum values were computed within each ROI.
Circulating glucose and triacylglycerols
Glucose and triacylglycerol levels were tested using kits purchased from Sigma and Wako Chemicals. Following microPET imaging, mice were anaesthetized and then blood was collected by cardiac puncture. Samples were then placed at 4
• C for 24 h to allow the decay of any remaining [ 18 F]FDG. Samples were then clarified by centrifugation (2000 g for 10 min at 22
• C) and the plasma was tested for glucose and triacylglycerol levels according to the manufacturer's protocol.
Cellular glucose uptake determinations
Primary myotubes were grown and differentiated in 24-well plates. Following a 16 h serum-starvation, differentiated primary myotubes were incubated in glucose-free DMEM for 10 min and then incubated in 0.5 μCi/ml [ 3 H]2-DG ([ 3 H]2-deoxyglucose; 0.25 μCi/well) and 100 μM non-radioactive 2-DG. Reactions were stopped with 0.05 M NaOH (250 μl/well) and analysed by scintillation counting. Glucose transport activity is expressed as pmol of 2-DG taken up/min per mg of total protein. Cytochalasin B (5 μmol/l) was used to determine non-specific transport.
Cellular ROS levels
Primary myoblasts were seeded, grown and differentiated in Matrigel TM -coated 96-well plates. Cells were then treated with menadione (0-20 μM) diluted in differentiating medium for 24 h, washed and then incubated for 30 min in 20 μM DCFH-DA (dichlorofluorescein-diacetate), as described in [27] . Absolute values were generated by subtracting the background fluorescence produced in the absence of DCFH-DA. Values were corrected for protein content/well.
Mitochondrial content
Mitochondrial content in WT and KO primary myotubes was tested using Mitotracker Green. Cells were washed twice with pre-warmed PBS and then treated for 15 min with Mitotracker Green (500 nM). Cells were then washed twice with PBS and fluorescence was measured at excitation and emission wavelengths of 480 nm and 528 nm respectively. Mean fluorescence values were corrected by substracting the background fluorescence produced in the absence of Mitotracker Green. Values were corrected for protein content/well.
Mitochondrial energization studies
The degree of mitochondrial energization following succinate titration was assessed using Safranin O. Skeletal muscle mitochondria from WT and KO mice were diluted to 1 mg/ml in Buffer A containing 5 μM Safranin O dye (excitation 485 nm, emission 580 nm) and incubated for 10 min at 37
• C. Mitochondria were then acutely treated with 1 mM glucose and 0.3 mM ATP for 1 min. Succinate was then added in successive increments to a final concentration of 10 mM to energize the mitochondria.
Mean fluorescence values were corrected by subtracting the fluorescence obtained from the mitochondria not treated with succinate. Data were expressed as the degree of energization.
HK-mediated control of mitochondrial ROS emission
Mitochondrial ROS production rates in the presence and absence of HK substrates were tested using DCFH-DA. Following the isolation of mitochondria from WT and KO primary myotubes, protein levels were determined using the Bradford assay. Reaction mixtures consisted of buffer A, 20 μl of isolated mitochondria, 20 μM DCFH-DA, 5 mM succinate, and the presence or absence of 1 mM glucose and 0.3 mM ATP. Reactions were performed for 10 min. Reactions performed in the absence of mitochondria were used to correct the absolute values to background fluorescence.
Metabolite analysis
ATP and TCA (tricarboxylic acid) cycle intermediate levels were measured as described in [28] . To test the effect of UCP3 on carbohydrate-mediated ATP production, CFE (cell-free extract) from C2C12 cells infected with either UCP3-adenovirus or RFP control virus was diluted to 1 mg/ml in buffer A containing either 10 mM glucose, 10 mM fructose or 5 mM/3 mM pyruvate/malate and 0.5 mM ADP. Reactions were performed at 37
• C for 30 min under constant agitation. TCA cycle intermediates were determined using CFE from C2C12 cells infected with either UCP3-adenovirus or RFP control virus diluted to 1 mg/ml in buffer A containing 10 mM glucose and 0.5 mM ADP, and incubated as described above. All reactions were stopped with perchloric acid diluted to 0.5 % in HPLC mobile phase [20 mM KH 2 PO 4 (pH 2.9)], clarified and then injected into the HPLC column. Samples were injected into a C 18 hydrophilic reversephase column operating at a flow rate of 0.7 ml/min (Synergi Hydro-RP, 4 μm, 250 mm×4.6 mm; Phenomenex). ATP, citrate, fumarate and α-oxoglutarate levels were monitored using an Agilent UV-Vis detector set to 254 nm for nucleotides and 210 nm for organic acids. Quantification was performed by injecting various amounts of standard metabolite solutions.
HK and CK (creatine kinase) activities
HK and CK assays were performed as described in [3] . For CK, 5 units of exogenous HK was added for the enzyme-coupled reaction. To test the effect of UCP3 inhibition/activation on HK activity, mitochondria were pre-incubated in the absence or presence of 0.5 mM GDP or 10 μM 4-HNE (4-hydroxy-2-nonenal) for 30 min at 37
• C in buffer A (respiratory substrates were excluded to avoid activation of any side reactions which may interfere with the determinations). Mitochondria were re-isolated by centrifugation (12 000 g at 4
• C for 10 min) and then used for HK activity measurements. Enzyme activity was monitored over a period of 10 min. Reactions were started by the addition of ATP. Reactions performed in the absence of protein served as the reagent control.
Glucose consumption by isolated mitochondria
Mitochondria were isolated from differentiated C2C12 cells infected with either adenoviral-UCP3 or empty vector control. Mitochondria were diluted to 1 mg/ml in buffer A and then reactions were performed for 15 min at 37
• C in the presence of 10 mM glucose and 0.5 mM ATP. Reactions containing 1 mM 2-DG served as a control for HK activity. Reactions were stopped by the addition of 50 μl of ice-cold 0.5 % perchloric acid, and the protein precipitate was pelleted by centrifugation at 12 000 g for 10 min. The supernatant was then placed in an ice-cold 1.5 ml mini-tube and adjusted to neutrality with 6 M KOH. The amount of glucose in each reaction was then determined using the glucose oxidase kit from Sigma. Determinations were performed according to the manufacturer's instructions.
Immunocapture of ANT complexes
The composition of multi-enzyme complexes formed with ANT was tested using an ANT immunocapture kit (Mitosciences). Immunocapture was performed according to the manufacturer's instructions. Mitochondria isolated from the skeletal muscle of WT and KO mice were diluted to 6 mg/ml in PBS containing 1 % (w/v) β-dodecyl-D-maltoside (maltoside) and incubated on ice for 30 min. Mitochondria not solubilized by maltoside were removed by centrifugation (12 000 g at 4
• C for 10 min) and the supernatant was incubated overnight in the requisite amount of anti-ANT agarose bead conjugate. Agarose-tagged protein complexes were then isolated according to the manufacturer's instructions and washed, followed by protein elution with PBS containing 4 M urea (pH 7.5). Protein fractions were diluted to ∼1 mg/ml, treated with Laemmli buffer and analysed by immunoblotting.
Immunoblotting
Mitochondria isolated from cells or skeletal muscle were treated accordingly for SDS/PAGE and electroblotted as described in [3] . Membranes were probed for 1-24 h with primary antibodies directed against HKII (1:1000 dilution, Calbiochem), complex III (1:1000 dilution, MitoSciences), ANT (1:1000 dilution, Santa Cruz Biotechnology) and UCP3 (1:1000 dilution, Abcam). SDH (1:3000 dilution, Santa Cruz Biotechnology) and actin (1:3000 dilution, Cell Signaling Technology) served as a loading control and mitochondrial purity standard. Membranes were then incubated for 1 h at room temperature (22 • C) with the requisite horseradish peroxidase-conjugated secondary antibodies (antirabbit or anti-mouse, 1:2000 dilution, Santa Cruz Biotechnology). Blots were incubated in ECL (enhanced chemiluminescent) substrate for visualization (ECL kit, Thermo Scientific).
Statistics
One-way ANOVA with a Tukey's post-hoc test (StatView software) and Student's t tests were used to assess statistical differences. Results are expressed as the averaged value + − S.D. unless otherwise indicated.
RESULTS

Knockout of UCP3 induces a metabolic shift that favours glycolysis
Whole-body metabolic measurements and studies with isolated mitochondria have established that UCP3 is involved in mitochondrial metabolism and anti-oxidative defence; however, the role of UCP3 in muscle metabolic networks in the 'fed state' has never been examined. Thus we first set out to determine the effect of knocking out UCP3 expression on cellular metabolism. For this set of experiments, we used primary myotubes from WT and UCP3-null (KO) mice to determine whether the presence or absence of UCP3 affected cellular fuel metabolism. These cells were routinely cultured and differentiated in high-glucosecontaining media to simulate fed-state conditions. In contrast with the WT primary myotubes, the KO cells displayed significant decreases in basal, state 4 (non-phosphorylating) and maximal O 2 consumption ( Figure 1A ). To investigate these metabolic changes further, we also determined the effect of UCP3 deletion on glycolytic flux. Basal ECAR (extracellular acidification/min) was significantly higher in the KO primary myotubes in comparison with the cells from the WT mice ( Figure 1B) . No detectable differences in ECAR were observed in either cell type following oligomycin or FCCP treatment; however, this is not surprising since both compounds are known to enhance the conversion of glucose into lactate [29] . To determine whether these differences between the WT and KO cells were due to changes in the respiratory complement, we immunoblotted for complexes II and III. As shown in Figure 1(C) , immunoblotting for complexes II and III in mitochondria isolated from WT and KO primary myotubes revealed no changes in the protein levels of either respiratory complex. The amount of mitochondria in the WT and KO primary myotubes was also tested using Mitotracker Green and fluorimetry. Indeed, Mitotracker Green fluorescence revealed no differences in the amount of mitochondria in WT and KO primary myotubes ( Figure 1D ). Hence these data indicate that the absence of UCP3 induces a metabolic shift that favours anaerobic metabolism over aerobic respiration.
To further examine the nature of the metabolic shift towards glycolysis, we measured glucose uptake in vivo by monitoring [
18 F]FDG uptake in the forelimb and hindlimb muscles of WT and KO mice fed a standard chow diet ad libitum. Following imaging, muscle regions in the forelimb and hindlimb were identified and then the amount of glucose uptake was quantified as the specific uptake value in g/ml ( Figure 2A , and Supplementary Movies S1 and S2 at http://www.BiochemJ.org/bj/437/bj4370301add.htm). The total [ 18 F]FDG uptake over a 1 h period in the forelimb and hindlimb skeletal muscle of KO mice showed a small, but significant, increase in comparison with the WT mice ( Figure 2B ). KO mice also displayed significantly lower circulating levels of glucose in comparison with the WT mice in the fed state ( Figure 2C ). Furthermore, KO mice also had significantly higher circulating triacylglycerol levels, in contrast with WT mice ( Figure 2C ). We also assessed whether these differences in glucose uptake could be observed in WT and KO primary myotubes grown and differentiated under high-glucose conditions. The rate of glucose uptake was higher in the KO cells in contrast with the WT, confirming that KO of UCP3 is accompanied by a metabolic shift that favours glycolysis ( Figure 2D ). 
UCP3 protects myotubes from oxidative stress
UCP3 is well known to protect skeletal muscle cells from oxidative stress. However, the ability of this protein to protect respiratory functions of mitochondria from oxidative damage under high-glucose conditions still remains untested. Indeed, it is well established that ROS are a potent inhibitor of aerobic respiration (TCA cycle and electron transport chain) [5, 30, 31] . Hence, we tested whether UCP3 protects mitochondrial metabolism from oxidative stress. For these determinations, we challenged primary myotubes from WT and KO mice with low amounts of menadione (0-20 μM), a superoxide-producing quinone, for 24 h and then tested mitochondrial bioenergetics in situ. We have previously established, using various cell types, that these low levels of menadione (<20 μM) increase cellular ROS without inducing cell death [3, 27] . WT and KO cells not exposed to menadione generated similar amounts of ROS. However, as shown in Figure 3(A) , cells lacking UCP3 displayed greater increases in ROS production in contrast with the WT cells following menadione treatment. Exposure to 10 μM menadione induced a sharp increase in ROS levels in the KO cells, whereas the WT cells displayed no change at this concentration, indicating that KO cells have a decreased capacity to handle ROS. The absence of UCP3 also sensitized aerobic metabolism to the menadionemediated increases in ROS. Exposure to 10 μM menadione resulted in a concomitant decrease in basal OCR in the KO cells. However, oligomycin-induced state 4 respiration or maximal O 2 consumption were largely unaffected by treatment with 10 μM menadione ( Figure 3C ). Concentrations of 20 μM menadione were required to depress non-phosphorylating and maximal O 2 consumption rates in the KO cells. In comparison, the WT cells were more resistant to the toxic effects of menadione, consistent with the protective effects of UCP3 against oxidative stress. State 4 OCR displayed a significant increase following a 24 h treatment with 10 μM menadione, consistent with the idea that UCP3 protects from oxidative stress by inducing non-phosphorylating respiration ( Figure 3B ). Basal OCR also tended towards an increase in the WT cells treated with 10 μM menadione; however, the change relative to control was insignificant. No changes in maximal O 2 consumption were observed in WT cells exposed to 10 μM menadione. Incubation in 20 μM menadione led to significant decreases in both basal and maximal O 2 consumption in the WT cells, indicating that the protective effect of UCP3 against ROS is somewhat limited ( Figure 3B ). State 4 OCR returned to control levels following treatment with 20 μM menadione. Hence, even in conditions that similate the fed state, UCP3 provides limited protection from oxidative stress.
UCP3 modulates mitochondria-bound HKII
HK recruitment to mitochondria increases when cells are provided high glucose, and this association diminishes ROS and enhances overall mitochondrial metabolic efficiency. Hence we next tested whether the absence or inhibition of UCP3 alters the activity of mitochondria-bound HK. First, we tested mitochondria isolated from skeletal muscle of WT and KO mice for HK activity. Intriguingly, the activity of HK was higher in the WT mitochondria in contrast with KO mitochondria ( Figure 4A ). This activity was inhibited by a 30 min preincubation in GDP, an inhibitor of UCP3. Next, we examined whether expression of UCP3 in cell lines could increase HK activity associated with mitochondria. Indeed, mitochondrial preparations from C2C12 myotubes and HEK-293 cells infected with adenoviral UCP3 vectors displayed higher HK activity in contrast with empty vector controls ( Figure 4B ). Moreover, preincubation of mitochondria with GDP inhibited the HK activity in a UCP3-dependent manner in both cell lines infected with adenoviral-UCP3. It is important to note that this pre-incubation in GDP did not affect the activity of HK in cytosolic fractions, indicating that the effects observed were strictly related to the GDP-mediated inhibition of UCP3 (Supplementary Figure  S2 at http://www.BiochemJ.org/bj/437/bj4370301add.htm). In addition, during the pre-incubation mitochondria were not provided with respiratory substrate to afford a proper analysis of the effect of UCP3 on HK activity. The observed increase in HK activity due to UCP3 was confirmed by measuring glucose utilization in mitochondria isolated from C2C12 cells infected with adenoviral-UCP3 or empty vectors. More glucose was metabolized by the mitochondria isolated from the C2C12 cells expressing UCP3 in contrast with the empty vector control ( Figure 4C ). Moreover, inclusion of 2-DG, an inhibitor of HK activity, in the reactions curtailed glucose use by the isolated mitochondria, confirming that HK is metabolically active in the preparations ( Figure 4C ). Overexpression of UCP3 is known to induce artificial uncoupling across the mitochondrial membrane [32] . To test whether transduction of C2C12 myotubes with adenoviral-UCP3 was altering cell respiration, we performed Seahorse analysis. As shown in Supplementary Figure S1 , basal OCR was similar between cells transduced with control or UCP3 vector. Assessment of maximal respiration with FCCP revealed that the mitochondria in the UCP3-expressing cells displayed a small, but significant, decrease in maximal respiration (Supplementary Figure S1) . We also tested whether pre-incubation of isolated mitochondria in 4-HNE, a reported allosteric activator of UCP3, could modulate mitochondriabound HK activity [33] . Following 4-HNE incubation, no changes in HK activity were observed between the mitochondria isolated from empty vector control and those from UCP3-expressing cells (Supplementary Figure S2) . The activity of mitochondrial CK was also examined in mitochondria from C2C12 cells infected with either adenoviral-UCP3 or empty vector. We found no changes in the activity of CK in the presence or absence of UCP3 (Supplementary Figure S2) . We also tested the activity of HK in mitochondria isolated from UCP3-overexpressing C2C12 cells grown and differentiated under low-glucose (5 mM) conditions (Supplementary Figure S2) . Intriguingly, no difference in HK activity was observed in mitochondria from C2C12 cells infected with either empty adenoviral or UCP3-adenoviral vectors, indicating that UCP3 functions through HK only when glucose is abundant. We next tested whether the augmented activity was associated with increased HK recruitment to mitochondria. Skeletal muscle mitochondria from WT mice contained higher levels of HKII in contrast with the mitochondria from the KO mice ( Figure 4D ). Pre-incubation of WT mitochondria in G6P (glucose 6-phosphate), which is known to remove HKII from the surface of mitochondria, diminished the intensity of the immunoreactive bands, confirming the presence of HKII. Since HKII is known to dock to VDAC/ANT, we hypothesized that a physical interaction between UCP3 and ANT influences HKII association with mitochondria. Immunocapture of ANT complexes revealed the presence of both VDAC and HKII, confirming that these three proteins form a complex with one another ( Figure 4E ). Additionally, higher amounts of HKII were detected in the immunocapture from the WT mitochondria. Less VDAC was also associated with ANT in mitochondria from skeletal muscle of KO mice; however, no UCP3 was detected in the ANT immunocapture. Hence we conclude that UCP3 does not physically associate with ANT.
UCP3-mediated modulation of HKII enhances overall metabolic efficiency under high-glucose conditions
da-Silva et al. [9] showed that glucose diminished mitochondrial ROS emission in a HK-dependent fashion. Since our findings indicate that UCP3 controls mitochondria-bound HKII, we hypothesized that the UCP3-mediated modulation of mitochondria-bound HKII would limit mitochondrial ROS emission by increasing ADP availability and decreasing the ψ m . It is important to note that low ADP and a high ψ m are associated with increases in mitochondrial ROS production. First, ROS emission was tested in mitochondria isolated from WT and KO primary myotubes incubated in the presence or absence of HKII substrates, glucose and ATP. ROS emission from muscle mitochondria of KO myotubes was similar in the absence or presence of glucose and ATP ( Figure 5A ). In contrast, addition of glucose and ATP to mitochondria from WT mice substantially decreased succinate-induced ROS emission ( Figure 5A ). Reactions performed in the presence of rotenone, an inhibitor of succinate-induced ROS production by reverse electron transfer, almost completely abolished ROS production. Next we tested whether these decreases in ROS production in the WT mitochondria were related to changes in the ψ m . In contrast with skeletal muscle mitochondria from KO mice, WT mitochondria had a decreased mitochondrial membrane potential when incubated in glucose and ATP ( Figure 5B ). Hence the UCP3-mediated control of HKII decreases mitochondrial ROS emission by maintaining a lower ψ m . We next tested whether the induced expression of UCP3 in C2C12 myotubes affected the efficiency of ATP production in the presence of glucose. C2C12 myotubes infected with adenoviral-UCP3 vectors generated more ATP than the C2C12 empty vector controls when carbohydrates were being metabolized ( Figure 5C ). Indeed, when UCP3 was present, more ATP was generated in the presence of glucose and fructose ( Figure 5C ). By contrast, no UCP3-dependent differences were observed when saturating amounts of malate/pyruvate (3 mM and 5 mM respectively) were used as substrates. We also tested whether the absence or presence of UCP3 affected TCA cycle intermediate pool size during glucose catabolism. For this, CFE from C2C12 cells infected with either adenoviral-UCP3 or empty vector was incubated for 30 min in glucose and ADP, and then tested for TCA cycle intermediate levels. A significant accumulation of α-oxoglutarate was observed in the empty vector cells when compared with the UCP3-expressing cells, consistent with dysfunctional TCA cycle flux ( Figure 5D ). However, no changes in other TCA cycle intermediates, such as citrate and fumarate, were observed. Hence the UCP3-mediated regulation of HKII on the mitochondrial surface enhances the efficiency of carbohydrate oxidation, leading to diminished ROS levels in the cell.
DISCUSSION
UCP3 is highly selectively expressed in skeletal muscle and has been linked to both ROS buffering and skeletal muscle fatty acid metabolism. This mitochondrial protein has also been shown to lessen diet-induced obesity and improve insulin sensitivity [34, 35] . How UCP3 participates in these processes remains a matter of debate. Notably, the role of UCP3 in these critical processes in the fed state has not previously been tested. In the present study, we used a combination of in vivo, in situ and in vitro techniques to study the function of UCP3 in the fed state. Cells were routinely cultured in high-glucose conditions to simulate post-prandial conditions. For in vivo work, mice were fed a standard (high carbohydrate) chow diet with free access to food. In the present study, we made the unique observation that UCP3 participates in both anti-oxidative defence and aerobic metabolism through a surprising interaction with HKII. Deletion of UCP3 or lack of its expression resulted in diminished HKII activity associated with mitochondrial fractions isolated from mouse muscle or cell lines. Immunoblots identified HKII as the isoenzyme associated with UCP3. Intriguingly, incubation of mitochondrial extracts with GDP, a known UCP3 inhibitor, impeded HK activity, indicating that UCP3 partakes in the control of HKII. The recruitment of either HKI or HKII to the surface of mitochondria is known to limit mitochondrial ROS emission and increase the efficiency of electron transfer through the respiratory complexes [36] [37] [38] . These favourable effects stem from the HKII-mediated phosphorylation of glucose to G6P on the surface of mitochondria, which increases ADP availability for coupled respiration. Indeed, primary myotubes from WT mice cultured under high-glucose conditions generated less ROS in comparison with their KO counterparts when incubated in glucose and ATP. However, one caveat to this suggested mechanism is that the resulting G6P generated by this reaction can feedback and interfere with HKII. We have previously shown that skeletal muscle mitochondria contain G6P dehydrogenase which could effectively prevent the G6P-mediated inhibition of HKII [3] . In addition, UCP3-mediated increases in mitochondrial HK activity were not observed in cells grown and differentiated in 5 mM glucose, suggesting that the UCP3-mediated regulation of HKII is operative only when glucose is abundant (e.g. in the fed state). Hence these observations also indicate that UCP3 acts through HKII to control mitochondrial ROS by maintaining efficient aerobic metabolism under conditions that simulate a postprandial state.
Previous studies have shown that ANT often forms multienzyme complexes with VDAC, HKII (or I), phosphate carrier, cyclophilin D and CK [11, 39, 40] . ANT has also been reported to form supercomplexes with the respiratory enzymes [41] . HKI or II binding to mitochondria is thought to be mediated between the N-terminal hydrophobic region of the enzyme and VDAC [39] . The regulation of HK recruitment and binding to the ADP/ATP exchanger in association with VDAC is intricate, involving a complex interplay between phosphorylation, acetylation and allosteric regulators such as G6P and magnesium [39, 42] . Owing to similarities in their proposed functions in proton leak, UCP3 and ANT have long been hypothesized to either form a complex or indirectly influence each other's functions [17, 43] . In fact, we recently provided bioenergetic evidence that UCP3 does influence proton leak through ANT [43] . Hence, in the present study, we hypothesized that UCP3 participates in HKII modulation by physically associating with ANT. We did observe less VDAC association with ANT in skeletal muscle mitochondria from KO mice, which may account for the decrease in mitochondrialbound HKII in the UCP3-null cells. However, immunocapture revealed that UCP3 does not associate with ANT. It would seem, based on experiments with the known UCP3 inhibitor GDP and immunocapture assays, that UCP3 influences mitochondrial HKII via mechanisms other than an association with ANT. GDP also inhibits ANT, which may account for the decrease in HKII activity. The knockout of UCP3, however, did diminish mitochondrialbound HKII, indicating that functional UCP3 regulates this process under conditions that simulate the 'fed state'. Hence, when glucose is abundant, UCP3 aids in marshalling the recruitment of HKII to mitochondria, which favourably maintains aerobic metabolism and curtails mitochondrial ROS production.
Skeletal muscle is known to account for approximately 80 % of the postprandial glucose uptake [26, 44] . In fact, UCP3 is expressed more in glycolytic than oxidative muscle fibres, and has been implicated in mediating glucose metabolism [45, 46] . In the present study, we used microPET imaging coupled with in vitro analyses to evaluate glucose uptake in the skeletal muscle of WT and KO mice in the fed state. We observed that KO skeletal muscle in vivo take(s) up more glucose than the WT mice. KO mice also displayed higher circulating triacylglycerols and lower glucose concentrations, suggesting perturbations in circulating metabolic fuel homoeostasis. In vitro, the KO primary myotubes displayed increased non-insulin-stimulated glucose uptake rates in contrast with WT myotubes. The increase in glucose uptake in the KO skeletal muscle cells is due to the increase in glycolysis since the KO cells are reliant on glycolytic metabolism for ATP. Indeed, primary KO myotubes were more glycolytic and displayed significantly lower rates of aerobic respiration. Moreover, lack of UCP3 sensitized cells to oxidative stress and the absence of UCP3 diminished the use of carbohydrates for aerobic ATP production. Hence the knockout of UCP3 increased glucose uptake in skeletal muscle; however, the findings of the present study reveal that this is due to metabolic dysfunction. In a previous publication from our group, Costford et al. [47] also observed that UCP3-null mice displayed increased glucose uptake in skeletal muscle which was matched by increased insulin sensitivity [47] . Other studies, however, have shown that UCP3 is required to maintain insulin sensitivity [35, 48] . Although the results of the present study are in agreement with the data accrued by Costford et al. [47] , insulin sensitivity was not tested in the present study. Indeed, our observations indicate that loss of UCP3 function induces metabolic inflexibility in skeletal muscle cells that favours glycolysis, although whether this has any effect on insulin sensitivity requires further study. The metabolic flexibility normally inherent to skeletal muscle allows this tissue to dynamically switch between different carbon sources in the postprandial or fasting conditions to satisfy organismal metabolic demands. Under pathological conditions, such as obesity or insulin resistance, metabolic flexibility is hindered and skeletal muscle is limited in its carbon source selection. Although the effect of fasting or insulin on UCP3-mediated regulation of mitochondrial HKII was not explored in the present study, based on our observations we conclude that the UCP3-HKII relationship aids in preserving metabolic efficiency under fed-state conditions.
It is now generally well accepted that UCP3 is part of the anti-oxidative stress machinery. UCP3 overexpression has been shown to decrease protein carbonyl formation and limit mitochondrial ROS production [20, 23] . Likewise, loss of UCP3 results in increased sensitivity to oxidative stress [19, 49] . This putative function of UCP3 has also been suggested to play an important role in exercise physiology. Indeed, Jiang et al. [44] have recently shown that UCP3 is up-regulated during exercise, a key response required to enhance ROS handling during increased aerobic respiration. Anderson et al. [23] made similar observations showing that exercise-induced increases in UCP3 expression were required to curtail mitochondrial ROS production during fatty acid oxidation. The manner in which UCP3 diminishes oxidative stress is still subject to much debate. Work performed with proteoliposomes and isolated mitochondria indicates that UCP3 functions as a bona fide uncoupler inducing proton leak in response to either increased ROS production, ψ m or fatty acid oxidation to control cellular ROS levels [17, 50, 51] . We have recently confirmed this observation showing that UCP3 is activated by ROS [52] . Moreover, in the present study we confirmed that mitochondria from UCP3-null cells produce more ROS when energized with succinate. However, other groups contend that UCP3 combats oxidative stress through mechanisms distinct from uncoupling the proton gradient. Lombardi et al. [53] recently confirmed previous observations that UCP3 can flips-flop lipid hydroperoxides across the mitochondrial inner membrane. In the present study, we observed that control of mitochondriabound HKII accounts for the ROS buffering role of UCP3 under The UCP3-mediated regulation of mitochondria-bound HKII promotes efficient aerobic metabolism and controls mitochondrial ROS emission in skeletal muscle cells exposed to postprandial (high-glucose) conditions. A fraction of the ATP generated by oxidative phosphorylation (OXPHOS) is used to phosphorylate glucose through the enzymatic action of HKII on the surface of mitochondria. The resulting ADP is then used for re-uptake and re-phosphorylation in the mitochondria. The net result is increased electron flow, decreased mitochondrial inner membrane potential, diminished ROS generation and improved substrate oxidation due to an increase in ADP availability.
high-glucose conditions. We also observed that chronic exposure to ROS increased state 4 respiration in a UCP3-dependent fashion. It is possible that UCP3 may function pleiotropically to limit oxidative stress. The mechanism(s) used by UCP3 to buffer cellular ROS may depend on the cellular/physiological conditions, metabolic state and relative levels of ROS. Toime and Brand [54] recently suggested that UCP3 functions in several capacities, including proton leak, to limit oxidative stress. To this end, we suggest that UCP3 functions in a similar capacity relying on HKII control to buffer mitochondrial ROS production in the postprandial state.
In the present study, we provide evidence showing that UCP3 partakes in the control of mitochondria-bound HKII. This novel observation provides a functional link between the roles of UCP3 in both aerobic metabolism and alleviation of oxidative stress under fed state or high-glucose conditions ( Figure 6 ). Unfortunately, the mechanism of UCP3-mediated HKII recruitment was not clarified in the present study. In consideration of our evidence and previous studies, UCP3 is likely to be a multi-functional protein that invokes numerous strategies under different metabolic and physiological conditions to maintain properly functioning skeletal muscle mitochondria.
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